Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-17

Clinical Trial Update: Natural History Study of Patients With Canavan Disease (CANinform Study)

View source ↗

Summary

This clinical trial update notes the completion of CANinform, a natural history study of Canavan disease sponsored by Aspa Therapeutics.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Aspa Therapeutics | Conditions: Canavan Disease | Status: COMPLETED